Press Releases NextCell Pharma AB

Equities

NXTCL

SE0009723125

Delayed Nasdaq Stockholm Other stock markets 01:27:29 29/05/2024 pm IST			5-day change	1st Jan Change
2.62 ^SEK	-31.05%		+86.06%	+1.52%

27/05	Nextcell Pharma AB Elects Hans-Peter Ekre as New Chairman of the Board	CI
25/04	NextCell Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Single treatment with ProTrans demonstrates long-term therapeutic effect over 5 years	28/05	AQ
Bulletin from the Extraordinary General Meeting of NextCell Pharma AB (publ)	27/05	AQ
NextCell publishes its Interim Report 2 2023/2024	25/04	AQ
Notice of Extraordinary General Meeting in NextCell Pharma AB (publ)	24/04	AQ
The Board of Directors of NextCell resolves on a rights issue of units of approximately SEK 40.1 million, subject to approval by an Extraordinary General Meeting	24/04	AQ
NextCell's daughter company Cellaviva granted permission to handle amniotic tissue	22/04	AQ
Anders Essen-Möller resigns as Chairman of the Board of Directors due to health reasons	19/04	AQ
The Swedish Medical Products Agency approves subgroup analysis in NextCell's ProTrans-Young study	27/03	AQ
NextCell establishes QVance to meet the Nordic's need for quality analytics	14/03	AQ
NextCell Pharma's updated growth strategy	27/02	AQ
NextCell Pharma presents at Redeye Theme: Regenerative Medicine/Cell Therapy	14/02	AQ
NextCell publishes its Interim Report 1 2023/2024	25/01	AQ
Updates regarding NextCell's Clinical Trials with ProTrans	24/01	AQ
NextCell Pharma has compiled a Q&A section	13/12	AQ
Repeated treatment with ProTrans is immunologically safe	06/11	AQ
NextCell publishes its Year-End Report 2022/2023	26/23/26	AQ
NextCell signs an agreement for a new tissue product	10/23/10	AQ
NextCell Pharma presents at the Advanced Therapies Europe conference	05/23/05	AQ
ProTrans and NextCell gain international attention	08/23/08	AQ
NextCell publishes its Interim Report 3 2022/2023	27/23/27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases NextCell Pharma AB

Equities

NXTCL

SE0009723125

Press Releases

Filters